Wakefield, Mass., April 25th, 2023- Myrtelle Inc., (“Myrtelle” or the “Company”), a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
HiRO and Differentia have signed a Memorandum of Understanding establishing a framework for joint development…
HiRO and Differentia have signed a Memorandum of Understanding establishing a framework for joint development…